Press Releases Archives - Page 18 of 103 - Lupin

BSE 2328.10 NSE 2324.50

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2328.10 NSE 2324.50

Lupin Launches Bromfenac Ophthalmic Solution, 0.07% in the United States

January 9, 2024

Lupin Launches Second Edition of Aptivate Champion Run for Kids Promoting Children’s Well-being Through Fitness and Nutrition

January 8, 2024

Lupin Receives Tentative Approval from U.S. FDA for Dapagliflozin and Saxagliptin Tablets

January 4, 2024

Lupin Receives Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Suspension, 0.2%

December 27, 2023

Lupin Launches Softovac Liquifibre, a first-of-its-kind liquid fibre

December 21, 2023

Lupin Receives Approval from U.S. FDA for Allopurinol Tablets

December 15, 2023

Lupin Receives Tentative Approval from U.S. FDA for Sitagliptin Tablets

December 15, 2023

Lupin Diagnostics Expands Presence in South India with New Regional Reference Laboratory in Chennai

December 14, 2023

Lupin Receives Approval from U.S. FDA for Varenicline Tablets

December 6, 2023

Lupin Launches Turqoz^®(Norgestrel and Ethinyl Estradiol) Tablets USP in the United States

December 1, 2023

1 2 … 17 18 19 … 102 103

Search

Hit enter to search or ESC to close